Viral kinetics in the treatment of chronic hepatitis C
Cytotoxic CD4+ T cells in viral hepatitis
Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus
Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection
Absence of HCV viral recombination following superinfection
Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon α-2b and ribavirin combination after liver transplantation
Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon α-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1
Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users